The influence of hyperglycemia on oxidation-reduction reaction of human umbilical vein endothelial cells;Wpływ hiperglikemii na procesy oksydacyjno-redukcyjne w komórkach śródbtonka ludzkiej żyły pepowinowej

Polski Merkuriusz Lekarski

Volumn 23, Issue 136, 2007, Pages 246-250

  Szczepański, Marek ^a   Kamianowska, Monika ^a   Skrzydlewska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hyperglycemia; Oxidative stress; Reactive oxygen species

Indexed keywords

MALONALDEHYDE;

ARTICLE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; METABOLISM; OXIDATION REDUCTION REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BLOOD GLUCOSE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERGLYCEMIA; MALONDIALDEHYDE; OXIDATION-REDUCTION; UMBILICAL VEINS;

EID: 35948937592     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bańkowski E., Biochemia. Urban & Partner. Wrocław, 2004, 89-120.
2. Bartosz G., Druga twarz tlenu. Wolne rodniki w przyrodzie. PWN. Warszawa, 2003.
3. Baynes J.W., Thorpe S.R.: Role of oxidative stress in diabetic complications: a new perspective on an. old paradigm. Diabetes, 1999, 48, 1-9.
4. Bayraktutan U.: Free radicals, diabetes and endothelial dysfunction. Diabetes Obes. Metab., 2002, 4, 224-238.
5. Brand M. D., Affourtit C., Esteves T.C. i wsp.: Mitochondrial Superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic. Biol. Med., 2004, 37, 755-767.
6. Ceriello A., Russo P., Amstad P. i wsp.: High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes, 1996, 45, 471-477.
7. Comporti M.: Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology. Free Radie. Res., 1998, 28, 623-635.
8. Cosentino F., Hishikawa K., Katusic Z.S. i wsp.: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation, 1997, 96, 25-28.
9. Cosentino F., Eto M., De Paolis P. i wsp.: High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation., 2003, 107, 1017-1023.
10. Dai Z., Jiang D. J., Hu G. Y. i wsp.: 3,4,5,6-tetrahydroxyxanthone protects against myocardial ischemia-reperfusion injury in rats. Cardiovasc. Drugs Ther., 2004, 18, 279-288.
11. Davi G., Falco A., Patrono C.: Lipid peroxidation in diabetes mellitus. Antioxid. Redox. Signal., 2005, 7, 256-268.
12. Du X. L., Sui G. Z., Stockklauser-Farber K i wsp.: Induction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia, 1998, 41, 249-256.
13. Duman B. S., Ozturk M., Yilmazeri S. i wsp.: Thiols, malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus. Tohoku. J. Exp. Med., 2003, 201, 147-155.
14. El-Remessy A. B., Abou-Mohamed G., Caldwell R.W. i wsp.: High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest. Ophthalmol. Vis. Sci., 2003,44, 3135-3143.
15. Giugliano D., Ceriello A., Paolisso G.: Oxidative stress and diabetic vascular complications. Diabetes Care, 1996, 19, 257-267.
16. Green K., Brand M. D., Murphy M. P.: Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes, 2004, 53, supl. 1: S110-S118.
17. Inoguchi T., Sonta T., Tsubouchi H. i wsp.: Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J. Am. Soc. Nephrol., 2003, 8, supl. 3, S227-S232.
18. Kowaltowski A.J., Castilho R.F., Vercesi A.E.: Mitochondrial permeability transition and oxidative stress. FEBS Lett., 2001, 495,12-15.
19. Lee H. B., Yu M. R., Yang Y. i wsp.: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol., 2003, 14, supl. 3, S241-S245.
20. Londero D., Lo Greco P.: Automated high-performance liquid Chromatographic separation with spectrofluorometric detection of malondialdehyde-thiobarbituric acid adduct in plasma. J. Chromatogr. A., 1996, 729, 207-210.
21. Mercuri F., Quagliaro L., Ceriello A.: Oxidative stress evaluation in diabetes. Diabetes Technol. Ther., 2000, 2, 589-600.
22. Moore K., Roberts L.J.: Measurement of lipid peroxidation. Free Radic. Res., 1998, 28, 659-671.
23. Nishikawa T., Edelstein D., Du X.L. i wsp.: Normalizing mitochondrial Superoxide production blocks three pathways of hyperglycaemic damage. Nature, 2000, 404, 787-790.
24. Pasaoglu H., Sancak B., Bukan N.: Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku. J. Exp. Med. 2004, 203, 211-218.
25. Quagliaro L., Piconi L., Assaloni R. i wsp.: Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes, 2003, 52, 2795-2804.
26. Sekiguchi N., Inoguchi T., Kobayashi K. i wsp.: Effect of erythropoietin on endothelial cell apoptosis induced by high glucose. Diabetes Res. Clin. Pract, 2004, 66, supl. 1, S103-S107.
27. Sharpe P.C., Liu W.H., Yue K.K. i wsp.: Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. Diabetes, 1998, 47, 801-809.
28. Starkov A.A., Chinopoulos C., Fiskum G.: Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell. Calcium, 2004, 36, 257-264.
29. Suzuki D., Miyata T., Saotome N. i wsp.: Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol., 1999, 10, 822-832.
30. Talior I., Tennenbaum T., Kuroki T. i wsp.: PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am. J. Physiol. Endocrinol. Metab., 2005, 288, E405-E411.
31. Uchida K.: 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog .Lipid Res., 2003, 42, 318-343.
32. Wardman P., Candeias L. P.: Fenton chemistry: an introduction. Radiat. Res., 1996, 145, 523-531.
33. Wautier J.L., Wautier M.P., Schmidt A.M. i wsp.: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl. Acad. Sci. USA, 1994, 9, 7742-7746.
34. Wolff S.P.: Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull., 1993, 49, 642-652.
35. Yamagishi S., Takeuchi M.: Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. Drugs Exp. Clin. Res., 2004, 30, 169-175.
36. Zoratti M., Szabo I., de Marchi U.: Mitochondrial permeability transitions: how many doors to the house? Biochim. Biophys. Acta, 2005, 1706, 40-52.